JP2006518355A - インドロピロロカルバゾール誘導体及び他の抗腫瘍薬を含む併用療法 - Google Patents

インドロピロロカルバゾール誘導体及び他の抗腫瘍薬を含む併用療法 Download PDF

Info

Publication number
JP2006518355A
JP2006518355A JP2006502025A JP2006502025A JP2006518355A JP 2006518355 A JP2006518355 A JP 2006518355A JP 2006502025 A JP2006502025 A JP 2006502025A JP 2006502025 A JP2006502025 A JP 2006502025A JP 2006518355 A JP2006518355 A JP 2006518355A
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
edotecarin
acceptable salt
pharmaceutical composition
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006502025A
Other languages
English (en)
Japanese (ja)
Inventor
チョメイ，マリーナ
ペセンティ，エンリコ
Original Assignee
ファルマシア イタリア ソチエタ ペル アツィオニ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファルマシア イタリア ソチエタ ペル アツィオニ filed Critical ファルマシア イタリア ソチエタ ペル アツィオニ
Publication of JP2006518355A publication Critical patent/JP2006518355A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Saccharide Compounds (AREA)
JP2006502025A 2003-02-21 2004-02-16 インドロピロロカルバゾール誘導体及び他の抗腫瘍薬を含む併用療法 Withdrawn JP2006518355A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000317A ITMI20030317A1 (it) 2003-02-21 2003-02-21 Terapia combinata comprendente un derivato dell'indolopirrolocarbazolo ed un altro agente antitumorale.
PCT/EP2004/050130 WO2004073719A1 (fr) 2003-02-21 2004-02-16 Traitement combine comprenant un derive d'indolopyrrolocarbazole et un autre agent antitumoral

Publications (1)

Publication Number Publication Date
JP2006518355A true JP2006518355A (ja) 2006-08-10

Family

ID=32894164

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006502025A Withdrawn JP2006518355A (ja) 2003-02-21 2004-02-16 インドロピロロカルバゾール誘導体及び他の抗腫瘍薬を含む併用療法

Country Status (10)

Country Link
EP (1) EP1599210A1 (fr)
JP (1) JP2006518355A (fr)
AR (1) AR043241A1 (fr)
BR (1) BRPI0407642A (fr)
CA (1) CA2516097A1 (fr)
CL (1) CL2004000319A1 (fr)
IT (1) ITMI20030317A1 (fr)
MX (1) MXPA05008879A (fr)
TW (1) TW200500073A (fr)
WO (1) WO2004073719A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014129416A (ja) * 2006-10-06 2014-07-10 Bavarian Nordic Inc Ｍｖａを使ってがんを処置する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441026B1 (en) * 1993-11-08 2002-08-27 Aventis Pharma S.A. Antitumor compositions containing taxane derivatives
EE200200471A (et) * 2000-02-28 2003-12-15 Aventis Pharma S.A. Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini või selle derivaati kombinatsioonis pürimidiini derivaadiga ning on ette nähtud vähktõve raviks

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014129416A (ja) * 2006-10-06 2014-07-10 Bavarian Nordic Inc Ｍｖａを使ってがんを処置する方法

Also Published As

Publication number Publication date
ITMI20030317A1 (it) 2004-08-22
AR043241A1 (es) 2005-07-20
WO2004073719A1 (fr) 2004-09-02
BRPI0407642A (pt) 2006-03-01
MXPA05008879A (es) 2005-10-05
EP1599210A1 (fr) 2005-11-30
TW200500073A (en) 2005-01-01
CA2516097A1 (fr) 2004-09-02
CL2004000319A1 (es) 2005-04-22

Similar Documents

Publication Publication Date Title
RU2587013C2 (ru) Комбинированная химиотерапия
US20120157472A1 (en) Method for treating colorectal cancer
JP2014132009A5 (fr)
MXPA01010138A (es) Docetaxel en combinacion con rhumas her2 para el tratamiento de canceres.
KR101628448B1 (ko) 암 치료에 사용하기 위한 베무라페닙 및 인터페론을 포함하는 병용 요법
JP5514123B2 (ja) 卵巣癌を治療するための、パクリタキセルを含む配合剤
JP2003533485A5 (fr)
KR20160135230A (ko) 암의 치료를 위한 병용 요법으로서의 에리불린 및 mTOR 억제제의 용도
JP2009536956A (ja) 抗癌治療法
ES2909741T3 (es) Tratamiento del cáncer
ES2330324T3 (es) Derivados del epotilon para el tratamiento del hepatoma y de otros canceres.
JP4672257B2 (ja) エポチロンを含む組成物およびカルチノイド症候群の治療のためのそれらの使用
CA3005961A1 (fr) Ligand du recepteur de l'adenosine a3 pour le traitement de l'accumulation de graisse ectopique
TW200306185A (en) Combinations comprising EPOTHILONES and anti-metabolites
US7863255B2 (en) Methods of administering antitumor agent comprising deoxycytidine derivative
JP2006518355A (ja) インドロピロロカルバゾール誘導体及び他の抗腫瘍薬を含む併用療法
TW201306833A (zh) 包含康布列塔司他汀（ｃｏｍｂｒｅｔａｓｔａｔｉｎｓ）族衍生物及西妥昔單抗（ｃｅｔｕｘｉｍａｂ）之組合
JP2023509191A (ja) 癌を治療するための組み合わせ療法
JP2004517821A (ja) 癌治療のためのカンプトセシン及びスチルベン誘導体からなる組合せ
ZA200508696B (en) Use of irinotecan for treatment of resistant breast cancer
KR20210039414A (ko) 암의 치료를 위한 병용 요법
JP2021533107A (ja) 癌を治療するための併用療法
ES2896051T3 (es) Fármaco antitumoral que contiene un complejo de platino antitumoral y un potenciador del efecto antitumoral
JPH0840903A (ja) 抗癌剤により誘発される末梢神経障害を予防するための医薬組成物
JP2023050198A (ja) ペンタアザ大環状環複合体および白金を基にした抗癌剤による組み合わせ癌療法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070115

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20071011

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20071011

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20090212